KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-21 Cr | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-21 Cr |
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹0.99 Cr |
| Mar2023 | ₹-20 Cr |
| Mar2022 | ₹123 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-21 Cr | Negative | |
| Mar2025 | ₹26 Cr | 2,515.57 | |
| Mar2024 | ₹0.99 Cr | Positive | |
| Mar2023 | ₹-20 Cr | Negative | |
| Mar2022 | ₹123 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹919.6 Cr | -0.8% | 4.6% | 18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -0.8% |
4.6% |
18.1% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses